Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating split-course chemoradiotherapy for locally advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: An Open Label, Multicenter, Phase II Study of Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases [Phase 2]
Phase II open-label study investigating dacomitinib for EGFR-mutated non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Glumetinib Combined With Osimertinib in the Treatment of Relapsed and Metastatic Non-small Cell Lung Cancer Patients Who Failed to Receive EGFR Inhibitors [Phase 1, Phase 2]
Phase 1/2 trial evaluating glumetinib with osimertinib for relapsed/refractory non-small cell lung cancer after EGFR inhibitor failure.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2, Phase 3]
Clinical trial update on paclitaxel and carboplatin with/without BMS-275291 in advanced or metastatic non-small cell lung cancer; trial phas…
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy [Phase 2]
Phase 2 trial comparing nintedanib with placebo for radiation-induced pneumonitis in patients with non-small cell lung cancer undergoing che…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed [Phase 3]
Phase 3 trial evaluating vinorelbine + cisplatin versus no further therapy after surgical resection in non-small cell lung cancer; completed…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating radiation therapy to relieve symptoms in non-small cell lung cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Etirinotecan Pegol (NKTR-102) in NSCLC [Phase 2]
A Phase 2 trial of Etirinotecan Pegol (NKTR-102) in metastatic and recurrent non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial update examining how gut microbiota relates to outcomes in brain metastasis from non-small cell lung cancer treated with pem…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020） [Phase 4]
Phase 4 study updates the use of anlotinib in patients with non-squamous non-small cell lung cancer after failure of first-line therapy.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC [Phase 4]
Phase 4 trial investigating low-dose gemcitabine in combination with nivolumab for second-line and later treatment in metastatic non-small c…
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers [Phase 3]
Phase 3 trial updating aprepitant for chemotherapy-induced nausea and vomiting in Chinese patients with advanced non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors [Phase 1]
Phase I study of lurbinectedin in combination with paclitaxel, with or without bevacizumab, in selected advanced solid tumors (completed; re…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating FKB238 in combination with Avastin for advanced/recurrent non-squamous non-small cell lung cancer has completed w…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study [Phase 2]
Phase 2 single-arm trial evaluating anlotinib with a PD-1/PD-L1 inhibitor as sequential therapy following thoracic radiotherapy after induct…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer. [Phase 2]
Phase 2 clinical trial update investigating local non-salvage radiotherapy for patients with synchronous oligometastatic stage IV non-small …
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3 [Phase 2]
Phase 2 clinical trial evaluating pemetrexed disodium in stage IV non-small cell lung cancer with poor performance status (ECOG 3).
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC） [Phase 3]
Phase 3 trial evaluating optimal timing of radiotherapy in oligometastatic stage IV non-small cell lung cancer is ongoing, with status curre…
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating TQB2450 injection with SBRT in advanced oligometastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC [Phase 2]
Phase 2 trial update evaluating camrelizumab combined with Endostar as first-line treatment for advanced squamous non-small cell lung cancer…
-
FDA approval · 2020-03-05FDA Approved: CARBOPLATIN — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for carboplatin filed by Apotex Corp., authorizing changes to an approved generic product.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY) [Phase 3]
This clinical trial update reports on RELAY, a Phase 3 study evaluating the combination of ramucirumab with erlotinib in previously untreate…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC [Phase 2]
Phase 2 trial update investigating stereotactic radiosurgery with anlotinib for limited brain metastases in NSCLC with perilesional edema.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC [Phase 2]
Phase 2 trial investigating PD-1 combined with dasatinib as third-line therapy for ARID1A-mutant advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC [Phase 3]
A phase 3 trial evaluating cisplatin and etoposide with radiation followed by nivolumab vs placebo in locally advanced non-small cell lung c…